Pro-Dex Past Earnings Performance
Past criteria checks 1/6
Pro-Dex's earnings have been declining at an average annual rate of -5%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 11.7% per year. Pro-Dex's return on equity is 16.9%, and it has net margins of 9.2%.
Key information
-5.0%
Earnings growth rate
-2.2%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 11.7% |
| Return on equity | 16.9% |
| Net Margin | 9.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
This Analyst Just Made A Massive Upgrade To Their Pro-Dex, Inc. (NASDAQ:PDEX) Earnings Forecasts
Nov 13
Pro-Dex, Inc. (NASDAQ:PDEX) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 05Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce
Sep 10The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence
Jul 18Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality
Feb 16Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly
Feb 14Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jan 24Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet
May 20Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital
Oct 05Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting
Sep 26When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?
Sep 20Pro-Dex GAAP EPS of $0.38, revenue of $12.61M
Aug 25Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
May 10Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?
Apr 21Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price
Mar 14Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?
Feb 09We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt
Nov 17Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?
Aug 29A History Of Strong Growth Rates: Pro-Dex On Sale
Aug 25The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising
May 18What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Mar 29Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 15The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted
Feb 26Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)
Feb 13
We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)
Feb 08Pro-Dex EPS misses by $0.27, misses on revenue
Feb 04Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?
Jan 25What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?
Jan 11How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?
Dec 28With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting
Dec 14What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?
Nov 30Revenue & Expenses Breakdown
How Pro-Dex makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 57 | 5 | 5 | 3 |
| 30 Jun 24 | 54 | 2 | 5 | 3 |
| 31 Mar 24 | 49 | 2 | 5 | 2 |
| 31 Dec 23 | 48 | 3 | 5 | 2 |
| 30 Sep 23 | 47 | 5 | 5 | 2 |
| 30 Jun 23 | 46 | 7 | 5 | 2 |
| 31 Mar 23 | 48 | 8 | 5 | 2 |
| 31 Dec 22 | 44 | 7 | 5 | 2 |
| 30 Sep 22 | 43 | 5 | 6 | 2 |
| 30 Jun 22 | 42 | 5 | 6 | 2 |
| 31 Mar 22 | 39 | 3 | 5 | 3 |
| 31 Dec 21 | 41 | 5 | 6 | 3 |
| 30 Sep 21 | 39 | 6 | 6 | 4 |
| 30 Jun 21 | 38 | 6 | 5 | 4 |
| 31 Mar 21 | 40 | 8 | 5 | 3 |
| 31 Dec 20 | 36 | 7 | 5 | 3 |
| 30 Sep 20 | 36 | 6 | 4 | 2 |
| 30 Jun 20 | 35 | 6 | 4 | 2 |
| 31 Mar 20 | 31 | 4 | 3 | 2 |
| 31 Dec 19 | 29 | 4 | 3 | 2 |
| 30 Sep 19 | 27 | 4 | 3 | 2 |
| 30 Jun 19 | 27 | 4 | 3 | 2 |
| 31 Mar 19 | 26 | 3 | 3 | 2 |
| 31 Dec 18 | 25 | 3 | 3 | 2 |
| 30 Sep 18 | 24 | 2 | 3 | 2 |
| 30 Jun 18 | 22 | 2 | 3 | 2 |
| 31 Mar 18 | 22 | 2 | 3 | 2 |
| 31 Dec 17 | 23 | 2 | 3 | 2 |
| 30 Sep 17 | 22 | 5 | 3 | 1 |
| 30 Jun 17 | 22 | 5 | 3 | 1 |
| 31 Mar 17 | 21 | 4 | 3 | 1 |
| 31 Dec 16 | 20 | 4 | 3 | 1 |
| 30 Sep 16 | 20 | 2 | 3 | 1 |
| 30 Jun 16 | 19 | 1 | 3 | 1 |
| 31 Mar 16 | 18 | 1 | 3 | 1 |
| 31 Dec 15 | 17 | 0 | 3 | 1 |
| 30 Sep 15 | 15 | 0 | 3 | 2 |
| 30 Jun 15 | 13 | 0 | 3 | 2 |
| 31 Mar 15 | 13 | 0 | 3 | 2 |
| 31 Dec 14 | 11 | -1 | 2 | 2 |
| 30 Sep 14 | 11 | -1 | 2 | 1 |
| 30 Jun 14 | 11 | -1 | 2 | 1 |
| 31 Mar 14 | 10 | -1 | 3 | 2 |
| 31 Dec 13 | 11 | -2 | 3 | 2 |
Quality Earnings: PDEX has high quality earnings.
Growing Profit Margin: PDEX's current net profit margins (9.2%) are lower than last year (11.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PDEX's earnings have declined by 5% per year over the past 5 years.
Accelerating Growth: PDEX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PDEX had negative earnings growth (-0.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (12.9%).
Return on Equity
High ROE: PDEX's Return on Equity (16.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 02:29 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pro-Dex, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |